NCT00043264View on ClinicalTrials.gov

Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis

PHASE2CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

Not specified

Conditions

Multiple Sclerosis

Interventions

DRUG

Rifampin

DRUG

Azithromycin

Trial Locations (1)

77030

University of Texas Medical School, Houston

All Listed Sponsors

collaborator

National Multiple Sclerosis Society

OTHER

lead

National Center for Research Resources (NCRR)

NIH